Milwaukee Bucks star Giannis Antetokounmpo had a message for his followers on Tuesday as the NBA world awaits the possibility of him finding a new team for the 2025-26 season.

"The Greek Freak" posted a slideshow of photos onto his Instagram page, showing himself working out on the basketball court. The shirt Antetokounmpo wore had four words.

CLICK HERE FOR MORE SPORTS COVERAGE ON FOXNEWS.COM

"Protect kids not guns," it read.

He accompanied the message for different colored hearts in the caption of the post. It is unclear what prompted the message.

Antetokounmpo has been caught up in trade rumors since a report came out at the beginning of this offseason that said the NBA champion’s time with the Bucks could be coming to a close.

Antetokounmpo was said to be "open-minded" about looking to continue his career elsewhere should he decide that his career with the Bucks had run its course, ESPN reported in May. NBA teams were reportedly expected to check in with Milwaukee more frequently than they have been to check the organization’s temperature on how close they are to trading him.

KNICKS' DEUCE MCBRIDE UNFAZED BY TEAM'S PROLONGED COACHING SEARCH FOLLOWING TOM THIBODEAU'S FIRING

No specific teams were named in the report, and it did not appear the Bucks were in active discussions to trade the two-time MVP. However, the team and Antetokounmpo’s reps were reportedly expected to talk about the future in the offseason.

The question of whether he would stay in Milwaukee loomed as soon as the Indiana Pacers eliminated the Bucks in the playoffs. He was asked in the immediate aftermath of the playoff loss whether he still believed he could win a second championship with the Bucks.

"I’m not going to do this. I’m not going to do this," Antetokounmpo said. "I know ... whatever I say, I know how it’s going to translate. I don’t know, man. I wish I was still playing. I wish I was still competing and going back to Milwaukee. I don’t know."

The NBA Draft is on Wednesday night, and it could be the perfect opportunity for the Bucks to find a suitor for Antetokounmpo.

Follow Fox News Digital’s sports coverage on X, and subscribe to the Fox News Sports Huddle newsletter.

Researchers at the San Carlos Clinical Hospital in Madrid may have targeted a potential solution for hair loss.

A recent study analyzed the effect of injecting mice's skin with stem cells from human fat —  "adipose-derived stem cells (ASCs)" — as a means of treating androgenetic alopecia (AGA), more commonly known as male- or female-pattern hair loss.

The team found that male mice achieved the best hair regrowth after three weeks when they received low-dose ASCs, combined with an energy-boosting molecule called adenosine triphosphate (ATP).

HAIRSTYLISTS AND MEDICAL EXPERT CONFIRM TEMPORARY HAIR LOSS AFFECTING OZEMPIC USERS

Low-dose and high-dose ASC treatments along with ATP led to no hair regrowth improvement in females, but medium-dose ASC plus ATP led to greater regrowth.

The researchers concluded that hair regrowth was improved in "all experimental groups" where male mice received stem cell solutions supplemented with ATP.

The findings were published in the journal Stem Cell Research & Therapy.

Lead study author Dr. Eduardo López Bran — dermatologist and professor at The Complutense University of Madrid — shared his expectations for the study in an interview with Fox News Digital.

THIS DAILY BEAUTY ROUTINE COULD BE RUINING YOUR HAIR, EXPERTS WARN

"We expected good results, but not such a high level of success," he said. "We’re talking about a very high degree of hair regrowth in both male and female mice."

With appropriate doses, the researchers achieved "very high percentages" of hair regrowth, noting that 100% of the male mice and up to 90% of the female mice regrew hair.

"These results demonstrate that advanced therapies may represent a new therapeutic approach for many diseases for which no effective treatments are currently available," Bran went on.

"Achieving such promising results in the preclinical phase with a completely novel approach to androgenetic alopecia — one that avoids chronic treatment and is also safe — is a significant scientific milestone."

The main limitation of the study was the thinness of mouse skin, Bran noted, which "posed a challenge in administering the therapy."

"This required the development of protocols to minimize experimental variability, and will be a key factor when studies in humans begin," he said.

These new findings should be "interpreted with caution and scientific rigor," Bran cautioned.

"Although the results in mice represent significant progress, it is also true that it is essential to wait for clinical benefits in humans to be confirmed."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The researcher encouraged those with androgenetic alopecia to continue consulting with their dermatologists and to follow prescribed treatments as research develops.

"It is important to remain hopeful. Research advances are pointing toward possible solutions that, in the future, may offer long-lasting results without the need for continuous treatment to maintain benefits," Bran added.

Looking ahead to human clinical trials, researchers are "actively working" on confirming safety for men and women between 18 and 50 years old with moderate androgenetic alopecia, the researcher noted.

"If everything progresses as expected, the most optimistic timeline points to the treatment becoming available in approximately five years," he said.

In a separate interview with Fox News Digital, Dr. Brendan Camp, M.D., a New York-based dermatologist who was not involved in the study, commented on the potential for this method.

"While not commercially available, this study suggests that injection of stem cells supplemented with ATP into scalp skin could potentially encourage hair regrowth in individuals with androgenetic alopecia," he reiterated.

For more Health articles, visit www.foxnews.com/health.

"This study is small, and more research is needed on this method as a potential treatment option for androgenetic alopecia."

Until then, Camp encourages people to focus on currently available and "well-studied" treatments to address hair loss, and to visit a board-certified dermatologist for evaluation.